![Theresa Heah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Theresa Heah
Direktor/Vorstandsmitglied bei
CURATIVE BIOTECHNOLOGY, INC.
Profil
Theresa G.
H.
Heah is the founder of Eyexora Global, Inc. Current jobs include Independent Director at Curative Biotechnology, Inc. since 2024; Member of The Royal College of Surgeons of Edinburgh; Member of the Royal College of Ophthalmologists; and Venture Partner at both Mitsui & Co. Global Investment, Inc. and Mitsui & Co. Global Investment Ltd. Former jobs include President & Chief Executive Officer at Intergalactic Therapeutics, Inc., Chief Executive Officer & Director at Paratus Sciences Corp., Vice President-Clinical Research & Medical Affairs at Aerie Pharmaceuticals, Inc., Chief Medical Officer at Beacon Therapeutics (USA), Inc. in 2019, and Chief Medical Officer & EVP-Operations at AsclepiX Therapeutics LLC.
Education includes an MBA from European School of Management & Technology GmbH and a doctorate from King's College London.
Aktive Positionen von Theresa Heah
| Unternehmen | Position | Beginn |
|---|---|---|
| CURATIVE BIOTECHNOLOGY, INC. | Direktor/Vorstandsmitglied | 31.03.2024 |
Royal College of Ophthalmologists
 Royal College of Ophthalmologists Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The Royal College of Surgeons of Edinburgh
 The Royal College of Surgeons of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Mitsui & Co. Global Investment, Inc.
 Mitsui & Co. Global Investment, Inc. Investment ManagersFinance Mitsui & Co Global Investment invests in companies located in the United States. The firm focuses on health, technology, food and retail service sectors. It participates in seed and later stage capital requirements. | Private Equity Investor | - |
Mitsui & Co. Global Investment Ltd.
 Mitsui & Co. Global Investment Ltd. Investment ManagersFinance Mitsui & Co invests in companies located in North America, Singapore, Japan and Europe. The firm focuses on healthcare and information technologies. It provides financing for seed and early stage capital requirements. | Private Equity Investor | - |
Ehemalige bekannte Positionen von Theresa Heah
| Unternehmen | Position | Ende |
|---|---|---|
AsclepiX Therapeutics LLC
 AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing drug technology | Geschäftsführer | 01.06.2021 |
| APPLIED GENETIC TECHNOLOGIES CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 31.12.2019 |
Paratus Sciences Corp.
 Paratus Sciences Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Vorstandsvorsitzender | - |
Intergalactic Therapeutics, Inc.
 Intergalactic Therapeutics, Inc. BiotechnologyHealth Technology Develops novel non-viral gene therapies for patients | Vorstandsvorsitzender | - |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Theresa Heah
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
31
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Curative Biotechnology, Inc.
 Curative Biotechnology, Inc. Electronics DistributorsDistribution Services Operates as a biopharmaceutical company which develops therapeutics, medical devices and diagnostics | Distribution Services |
European School of Management & Technology GmbH
 European School of Management & Technology GmbH Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that discovers, develops and commercializes ophthalmic therapies for the treatment of patients with eye diseases | Health Technology |
Mitsui & Co. Global Investment, Inc.
Mitsui & Co. Global Investment, Inc. Investment ManagersFinance Mitsui & Co Global Investment invests in companies located in the United States. The firm focuses on health, technology, food and retail service sectors. It participates in seed and later stage capital requirements. | Finance |
Beacon Therapeutics (USA), Inc.
 Beacon Therapeutics (USA), Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical research and development company that provides gene therapy development & clinical research services | Health Technology |
Mitsui & Co. Global Investment Ltd.
Mitsui & Co. Global Investment Ltd. Investment ManagersFinance Mitsui & Co invests in companies located in North America, Singapore, Japan and Europe. The firm focuses on healthcare and information technologies. It provides financing for seed and early stage capital requirements. | Finance |
King's College London
 King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Surgeons of Edinburgh
The Royal College of Surgeons of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Royal College of Ophthalmologists
Royal College of Ophthalmologists Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AsclepiX Therapeutics LLC
AsclepiX Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Engages in researching and developing drug technology | Commercial Services |
Intergalactic Therapeutics, Inc.
Intergalactic Therapeutics, Inc. BiotechnologyHealth Technology Develops novel non-viral gene therapies for patients | Health Technology |
Paratus Sciences Corp.
Paratus Sciences Corp. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
